CRISPR Therapeutics AG
NasdaqGM:CRSP
$ 56.38
+ $1.17 (2.09%)
$ 56.38
+ $1.17 (2.09%)
Real-time: 05/07/2024 12:12

CRSP - CRISPR Therapeutics Stock Prediction 2025 - 2030

8 years of reliable CRISPR Therapeutics stock forecast. The Wall Street analysts predict Outperform for CRSP. See at a glance whether NasdaqGM:CRSP will rise in the future.

$0.00
Forecast 2023
$66.20
Forecast 2025
$103.55
Forecast 2030
Underperform
TopGraphs Quality Ranking
Forecast 2023
$0.00
Forecast 2025
$66.20
Forecast 2030
$103.55
TopGraphs Quality Ranking
Underperform

Company Info

P/E
0.00
Beta
1.79
Price-to-book Ratio
2.43
Market Cap
4.50B
TEV
5.46 B
Dividend
$0.00
Div Yld
0.00%
Forecast 1Y
0.00%
Forecast 2Y
0.00%
Analyst Price Target
$86.67

CRISPR Therapeutics Price Chart

1M 3M YTD 1Y 2Y 5Y 10Y 20Y

CRISPR Therapeutics Stock Forecast 2023

$87.50

In the last five quarters, CRISPR Therapeutics’s Price Target has fallen from $104.37 to $86.67 - a -16.96% decrease. Twenty-three analysts predict that CRISPR Therapeutics’s share price will increase in the coming year, reaching $87.50. This would represent an increase of 0.96%.

53.35%
53.35
Last update: 05/07/2024

Highest Price Target $199.00

Average Price Target $87.50

Lowest Price Target $30.00

CRISPR Therapeutics Stock Prediction 2025

CRISPR Therapeutics Stock Predictions for Jan 2025.

In January 2025 analysts predict a stock price of $61.00. An increase of 6.91% compared to the previous month's estimate.

CRISPR Therapeutics Stock Predictions for Feb 2025.

In February 2025 analysts predict a stock price of $61.48. An increase of 7.74% compared to the previous month's estimate.

CRISPR Therapeutics Stock Predictions for Mar 2025.

In March 2025 analysts predict a stock price of $61.95. An increase of 8.57% compared to the previous month's estimate.

CRISPR Therapeutics Stock Predictions for Apr 2025.

In April 2025 analysts predict a stock price of $62.42. An increase of 9.39% compared to the previous month's estimate.

CRISPR Therapeutics Stock Predictions for May 2025.

In May 2025 analysts predict a stock price of $62.89. An increase of 10.22% compared to the previous month's estimate.

CRISPR Therapeutics Stock Predictions for Jun 2025.

In June 2025 analysts predict a stock price of $63.36. An increase of 11.05% compared to the previous month's estimate.

CRISPR Therapeutics Stock Predictions for Jul 2025.

In July 2025 analysts predict a stock price of $63.84. An increase of 11.88% compared to the previous month's estimate.

CRISPR Therapeutics Stock Predictions for Aug 2025.

In August 2025 analysts predict a stock price of $64.31. An increase of 12.7% compared to the previous month's estimate.

CRISPR Therapeutics Stock Predictions for Sep 2025.

In September 2025 analysts predict a stock price of $64.78. An increase of 13.53% compared to the previous month's estimate.

CRISPR Therapeutics Stock Predictions for Oct 2025.

In October 2025 analysts predict a stock price of $65.25. An increase of 14.36% compared to the previous month's estimate.

CRISPR Therapeutics Stock Predictions for Nov 2025.

In November 2025 analysts predict a stock price of $65.73. An increase of 15.19% compared to the previous month's estimate.

CRISPR Therapeutics Stock Predictions for Dec 2025.

In December 2025 analysts predict a stock price of $66.20. An increase of 16.01% compared to the previous month's estimate.

CRISPR Therapeutics Stock Forecast 2030

Stock Forecast for the Price of an CRISPR Therapeutics Share in Jan 2030.

In January 2030, analysts believe the stock price will be $95.42. An increase of 67.23% compared to the previous month's estimate.

Stock Forecast for the Price of an CRISPR Therapeutics Share in Feb 2030.

In February 2030, analysts believe the stock price will be $96.16. An increase of 68.53% compared to the previous month's estimate.

Stock Forecast for the Price of an CRISPR Therapeutics Share in Mar 2030.

In March 2030, analysts believe the stock price will be $96.90. An increase of 69.82% compared to the previous month's estimate.

Stock Forecast for the Price of an CRISPR Therapeutics Share in Apr 2030.

In April 2030, analysts believe the stock price will be $97.64. An increase of 71.11% compared to the previous month's estimate.

Stock Forecast for the Price of an CRISPR Therapeutics Share in May 2030.

In May 2030, analysts believe the stock price will be $98.38. An increase of 72.41% compared to the previous month's estimate.

Stock Forecast for the Price of an CRISPR Therapeutics Share in Jun 2030.

In June 2030, analysts believe the stock price will be $99.11. An increase of 73.7% compared to the previous month's estimate.

Stock Forecast for the Price of an CRISPR Therapeutics Share in Jul 2030.

In July 2030, analysts believe the stock price will be $99.85. An increase of 75% compared to the previous month's estimate.

Stock Forecast for the Price of an CRISPR Therapeutics Share in Aug 2030.

In August 2030, analysts believe the stock price will be $100.59. An increase of 76.29% compared to the previous month's estimate.

Stock Forecast for the Price of an CRISPR Therapeutics Share in Sep 2030.

In September 2030, analysts believe the stock price will be $101.33. An increase of 77.59% compared to the previous month's estimate.

Stock Forecast for the Price of an CRISPR Therapeutics Share in Oct 2030.

In October 2030, analysts believe the stock price will be $102.07. An increase of 78.88% compared to the previous month's estimate.

Stock Forecast for the Price of an CRISPR Therapeutics Share in Nov 2030.

In November 2030, analysts believe the stock price will be $102.81. An increase of 80.17% compared to the previous month's estimate.

Stock Forecast for the Price of an CRISPR Therapeutics Share in Dec 2030.

In December 2030, analysts believe the stock price will be $103.55. An increase of 81.47% compared to the previous month's estimate.

P/E
0.00
Beta
1.79
Price-to-book Ratio
2.43
Market Cap
4.50B
TEV
5.46 B
Dividend
$0.00
Div Yld
0.00%
Forecast 1Y
0.00%
Forecast 2Y
0.00%
Analyst Price Target
$86.67

CRISPR Therapeutics Analyst Ratings Frequently Asked Questions

Who are the analysts watching CRISPR Therapeutics AG?

The following analysts have recently covered CRISPR Therapeutics:

Baird
Barclays
BMO Capital Markets Equity Research
BofA Global Research
Brookline Capital Markets
Cantor Fitzgerald & Co.
Chardan Capital Markets, LLC
Citigroup Inc
Citigroup Inc. Research
Evercore ISI
Goldman Sachs
Guggenheim Securities, LLC
Jefferies LLC
JMP Securities
Leerink Partners LLC
Marktfeld
Mizuho Securities USA LLC
Morgan Stanley
Morningstar Inc.
Needham & Company
Oppenheimer & Co. Inc.
Piper Sandler Companies
Raymond James & Associates
RBC Capital Markets
Stifel
TD Cowen
Truist Securities
Wells Fargo Securities, LLC
William Blair & Company L.L.C.
Sanford C. Bernstein & Co., LLC
Wolfe Research, LLC.
CGS International
(This information refers to the last 90 days.)

Who are the sell-side analysts watching CRISPR Therapeutics AG?

The following sell-side analysts have recently covered CRISPR Therapeutics:

Allen, Jack Kilgannon
Wang, Huidong
Biliouris, Konstantinos
Meacham, Geoffrey Christopher
Cann, Leah Rush Vivian
Schmidt, Eric Thomas
Seedhouse, Steven James
Livshits, Yevgeniya
Nochomovitz, Yigal Dov
Bayko, Liisa Ann
Richter, Salveen Jaswal
Goodwin, Kelsey Beatrice
Raycroft, Maurice Thomas
Tuerkcan, Silvan Can
Foroohar, Mani
Paraskevopoulos, Michail
Syed, Salim Qader
Flynn, Terence C.
Elfman, Rachel
Blum, Gil Joseph
Olson, Jay
Tenthoff, Edward Andrew
Issi, Luca
Burnett, Benjamin Jay
Van Buren, Tyler Martin
Lee, Joon So
Zhu, Yanan
Lugo, Timothy Francis
Pickering, William
Chen, Gao Yi
(This information refers to the last 90 days.)